Urinary androgen
Urinary androgen
Urinary androgen
Urinary androgen
Urinary androgen
a urinary metabolite of cortisol metabolism
Urinary androgen
Urinary androgen
AspirinWorks® (11-dehydro thromboxane B2/Creatinine, or 11-dhTXB2/Creatinine) is a unique biomarker used to evaluate the effectiveness of aspirin in inhibiting thromboxane production, which is crucial for platelet function and clot formation. This biomarker specifically measures the levels of 11-dehydro thromboxane B2 (11-dhTXB2) in the urine, which is a stable metabolic product of thromboxane A2, the molecule that aspirin targets to reduce platelet aggregation. By normalizing this measurement to creatinine, a byproduct of muscle metabolism consistently present in urine, the test provides a reliable assessment of thromboxane production on a per kidney filtration rate basis. The AspirinWorks® test is particularly useful for determining if patients on low-dose aspirin therapy are receiving the appropriate antiplatelet effect to prevent conditions like heart attacks and strokes. This test is crucial for identifying aspirin resistance, a condition where individuals do not respond to the standard antiplatelet effects of aspirin, thus allowing for adjustments in their therapeutic regimen. Understanding the level of 11-dhTXB2 can help healthcare providers make more informed decisions regarding aspirin dosing, potentially leading to better cardiovascular outcomes for patients at risk of thrombotic events.
can be indicative of rheumatoid arthritis (RA) and erosive psoriatic arthritis.
14-3-3 eta: a highly specific RA marker that adds ~15% diagnostic sensitivity beyond RF/anti-CCP; >0.50 ng/mL predicts faster radiographic progression.
A major metabolite of estrone
A major metabolite of estrone
Percentages of 2-OH-E1, 4-OH-E1, and 16-OH-E1 When evaluating phase I metabolism, it can be helpful to compare the percentages of 2, 4, and 16 OH-E1 metabolites. Most individuals metabolize the majority of their estrogens down the 2-OH-E1 pathway which is generally considered the “safer pathway”. This is followed by 16-OH-E1 and 4-OH-E1 respectively, both of which are deemed more reactive and potentially genotoxic.
a metabolite of estrogen
A major metabolite of estrone
16α-Hydroxyestrone serves as an important indicator of estrogen metabolism pathways in the body. This compound is a metabolite of estrone (E1), formed through the hydroxylation process at the 16th carbon of the steroid structure. The balance of 16α-Hydroxyestrone, relative to other estrogen metabolites, is particularly significant in assessing hormonal health and the risk of estrogen-related disorders. Elevated levels of this metabolite are often linked to an increased risk of estrogen-sensitive conditions, such as certain types of breast and endometrial cancers. This is because 16α-Hydroxyestrone is a potent estrogen metabolite that can bind to estrogen receptors, potentially stimulating cellular proliferation in estrogen-sensitive tissues. In the context of a comprehensive hormone panel, measuring 16α-Hydroxyestrone provides insight into the specific pathways of estrogen metabolism that predominate in an individual, enabling a more personalized approach to understanding hormonal balance and associated health risks. An optimal hormonal balance involves a harmonious ratio between 16α-Hydroxyestrone and other metabolites like 2-hydroxyestrone, which is considered to be a less potent and potentially protective metabolite. For managing elevated levels of 16α-Hydroxyestrone, strategies typically focus on modifying factors that influence estrogen metabolism. This includes dietary interventions, such as increasing the intake of cruciferous vegetables, which contain compounds like indole-3-carbinol that can favorably alter estrogen metabolism. Lifestyle modifications like regular exercise, maintaining a healthy body weight, and reducing alcohol consumption are also important, as they can impact overall estrogen levels and metabolism. In some cases, supplements or medications that influence estrogen metabolism, such as selective estrogen receptor modulators (SERMs), may be prescribed. Monitoring and re-evaluating hormone levels periodically are essential components of managing and optimizing hormonal health, especially when interventions are in place to modulate estrogen metabolism.